| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine, Lombardi Cancer Center [J. S. M., L. E.], Institute for Health Care Research and Policy [J. S. M.], and Department of Biostatistics and Biomathematics [K. G.], Georgetown University, Washington, DC 20007, and Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 [P. K.]
The objective of this study was to test the hypothesis that HIV interacts with human papilloma virus (HPV) to increase the odds of cervical neoplasia.
The study design was a meta-analysis using data pooled from published sources. Studies published between January 1986 and March 1998 were eligible for inclusion if they included data on neoplasia (cytology-based), HIV (defined by laboratory and/or standard clinical criteria), and HPV (assessed by PCR, Southern blot, dot-blot hybridization, or cytology of an otherwise well designed study) among nonpregnant women. Blinded data abstraction was performed independently by the investigators.
There were 15 studies that were eligible and presented data in a format that could be abstracted for analysis. Data were pooled using a Mantel-Haenszel summary odds ratio (OR); generalized estimation regression equations were used to examine independent effects of HIV and HPV. Overall, based on the Mantel-Haenszel ORs, there was a strong overall association between HPV and neoplasia [OR, 8.1; 95% confidence interval (CI), 6.510.1]. Stratifying by HIV status, HIV-positive women had higher odds of disease (OR, 8.8; 95% CI, 6.312.5) than HIV-negative women (OR, 5.0; 95% CI, 3.76.8). In the regression model, there was an interaction between HPV and HIV (P = 0.01); immunosuppression also tended to predict neoplasia (P = 0.058).
HIV seems to be a cofactor in the association between HPV and cervial neoplasia; this effect may vary by level of immune function. These speculations are biologically plausible. Additional data from large, well designed studies are needed to confirm these hypotheses.
This article has been cited by other articles:
![]() |
P. Lehtovirta, J. Paavonen, and O. Heikinheimo Risk factors, diagnosis and prognosis of cervical intraepithelial neoplasia among HIV-infected women Int J STD AIDS, January 1, 2008; 19(1): 37 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sobhani, F. Walker, T. Aparicio, L. Abramowitz, D. Henin, A. C. Cremieux, and J. C. Soule Effect of Anal Epidermoid Cancer-related Viruses on the Dendritic (Langerhans') Cells of the Human Anal Mucosa Clin. Cancer Res., September 1, 2002; 8(9): 2862 - 2869. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Mandelblatt, W. F. Lawrence, S. M. Womack, D. Jacobson, B. Yi, Y.-t. Hwang, K. Gold, J. Barter, and K. Shah Benefits and Costs of Using HPV Testing to Screen for Cervical Cancer JAMA, May 8, 2002; 287(18): 2372 - 2381. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Thomas, R. M. Ray, J. Kuypers, N. Kiviat, A. Koetsawang, R. L. Ashley, Q. Qin, and S. Koetsawang Human Papillomaviruses and Cervical Cancer in Bangkok. III. The Role of Husbands and Commercial Sex Workers Am. J. Epidemiol., April 15, 2001; 153(8): 740 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Frisch, R. J. Biggar, and J. J. Goedert Human Papillomavirus-Associated Cancers in Patients With Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome J Natl Cancer Inst, September 20, 2000; 92(18): 1500 - 1510. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. HEARD, J.-M. TASSIE, V. SCHMITZ, L. MANDELBROT, M. D. KAZATCHKINE, and G. ORTH Increased Risk of Cervical Disease Among Human Immunodeficiency Virus-Infected Women With Severe Immunosuppression and High Human Papillomavirus Load Obstet. Gynecol., September 1, 2000; 96(3): 403 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Ruche, B. You, V. Leroy, C. Welffens-Ekra, and F. Dabis Correspondence re: J. S. Mandelblatt et al., Is HIV Infection a Cofactor for Cervical Squamous Cell Neoplasia? Cancer Epidemiol. Biomark. Prev., 8: 97-106, 1999 Cancer Epidemiol. Biomarkers Prev., August 1, 1999; 8(8): 729 - 730. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |